|
US 6,982,089 B2 |
|
Cytokine antagonists for neurological and neuropsychiatric disorders |
Edward Lewis Tobinick, Los Angeles, Calif. (US) |
Assigned to TACT IP, LLC, Highland Beach, Fla. (US) |
Filed on Oct. 09, 2002, as Appl. No. 10/269,745. |
Application 10/269745 is a continuation in part of application No. 10/236097, filed on Sep. 06, 2002, abandoned. |
Application 10/236097 is a continuation in part of application No. 09/841844, filed on Apr. 25, 2001, granted, now 6,537,549. |
Application 09/841844 is a continuation in part of application No. 09/826976, filed on Apr. 05, 2001, granted, now 6,419,944. |
Application 09/826976 is a continuation in part of application No. 09/563651, filed on May 02, 2000, granted, now 6,471,961. |
Application 09/563651 is a continuation in part of application No. 09/476643, filed on Dec. 31, 1999, granted, now 6,177,077. |
Application 09/476643 is a continuation in part of application No. 09/275070, filed on Mar. 23, 1999, granted, now 6,015,557. |
Application 09/275070 is a continuation in part of application No. 09/256388, filed on Feb. 24, 1999, abandoned. |
Prior Publication US 2003/0049256 A1, Mar. 13, 2003 |
This patent is subject to a terminal disclaimer. |
Int. Cl. A61K 9/00 (2006.01); A61K 39/40 (2006.01)
|